Pancreatitis
Conditions
Brief summary
Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common. In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury in the course of COVID 19 disease.
Interventions
OTHERbiochemical analysis
cRP, d-dimer levels and lymphocyte counts will be compared
Sponsors
Uşak University
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with amylase and lipase levels measured during covid-19 disease with or without pneumonia
Exclusion criteria
* Patients with pregnancy * Patients whose amylase and lipase levels were not measured during covid 19 disease * Patients with known solid organ malignacy * Patients with known hematologic malignacy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| to compare presence of fever in patients with and without pancreatic injury | 3 month | To evaluate the frequency of presence of fever in patients with and without pancreatic injury |
| to compare presence of dyspnea in patients with and without pancreatic injury | 3 month | To evaluate the frequency of presence of dyspnea in patients with and without pancreatic injury |
| To compare cRP levels in patients with and without pancreatic injury | 3 month | CRP levels will be compared in patients with and without pancreatic injury |
| To compare d-dimer levels in patients with and without pancreatic injury | 3 month | D-Dimer levels will be compared in patients with and without pancreatic injury |
Countries
Turkey (Türkiye)
Outcome results
None listed